GLP-1 Users Saw Lower Risks of Heart Attack and Stroke in Major Study
The lead author anticipated GLP-1s would improve blood sugar more than metformin. Other findings were harder to predict.
We haven't written up this one. Newsweek has the full story — the link below goes straight to it.